| abstract |
Although the fields of therapeutic applications ofndendritic cells are now expanding, dendritic cell precursorsnexist only in a small amount in the peripheral blood and,ntherefore, it is still difficult to obtain them in antherapeutically useful amount even though they arenproliferated in vitro. Therefore, it is a key point innperforming a therapy with the use of dendritic cells in practicento elevate dendritic cell precursor level in the peripheralnblood of a patient. n The present invention provides an agent for elevatingndendritic cell precursor level in the blood which comprisesnan agonist to a receptor expressed in immature dendritic cellsnor a functional derivative thereof as the active ingredient. |